MyHealthChecked Plc
("MyHealthChecked" or the "Company")
Director/PDMR Shareholding
Non-Executive Chairman buys 1m shares
MyHealthChecked plc (AIM:MHC), the consumer home-testing healthcare company, announces that it was notified that on 3 August 2022 Adam Reynolds, Non-Executive Chairman, purchased a total of 1,000,000 (one million) ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 1.7 pence per Ordinary Share.
Following this transaction, Adam Reynolds' total direct and indirect interest in the Company is 10,513,293 Ordinary Shares representing approximately 1.35% of the Group's total issued share capital.
The Notification of Dealing Form required in accordance with UK MAR is set out below.
For further information contact:
| MyHealthChecked plc | ||
| Penny McCormick, Chief Executive Officer | via Walbrook PR | |
| | | |
| SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
| Neil Baldwin | | |
| | | |
| Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
| Mike Seabrook | ||
| | | |
| Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com | |
| Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Adam Reynolds | |||
| 2
| Reason for the notification
| ||||
| a)
| Position/status
| Non-Executive Chairman | |||
| b)
| Initial notification /Amendment
| Initial Notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| MYHEALTHCHECKED plc | |||
| b)
| LEI
| 213800RBHY6LZDG13168
| |||
| CO4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary Shares
| |||
| | | ||||
| Identification code | ISIN: GB00BYZ2R301 | ||||
| | | ||||
| b)
| Nature of the transaction
| Purchase of Ordinary Shares | |||
| c)
| Price(s) and volume(s) | |
| | |
| | | Price(s) | Volume(s) | | |
| | | 1.7 pence | 1,000,000 | | |
| | |
| | | |
| d)
| Aggregated information | | |||
| | | ||||
| - Aggregated volume | N/A - Single Transaction | ||||
| | | ||||
| - Price | | ||||
| | | ||||
| e)
| Date of the transaction
| 3 August 2022 | |||
| f)
| Place of the transaction
| London Stock Exchange - AIMX | |||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
